Jaguar Health Secures $350K in Short-Term Notes and Issues Dilutive Warrants to Fund Working Capital

summarizeSummary

Jaguar Health raised $350,000 via short-term promissory notes and issued warrants for 350,000 shares, providing working capital but signaling financial pressure and potential significant dilution.

check_boxKey Events

• Securities Purchase Agreement

  Jaguar Health, Inc. entered into securities purchase agreements with two accredited investors on January 5, 2026.

• Issuance of Promissory Notes

  The company issued $350,000 aggregate principal amount of unsecured promissory notes. These notes bear interest at 6% per annum and mature in one month, with prepayment allowed without penalty.

• Issuance of Common Stock Warrants

  Investors received warrants to purchase up to an aggregate of 350,000 shares of common stock. The warrants are immediately exercisable at an initial exercise price of $1.00 per share and expire in five years.

• Use of Proceeds

  The proceeds from this financing will be used for working capital and other general corporate purposes.

auto_awesomeAnalysis

Jaguar Health, a micro-cap company, has secured $350,000 through unsecured promissory notes and issued warrants for 350,000 shares. While the capital infusion provides immediate working capital, the terms suggest financial urgency. The notes mature in just one month, and the warrants are exercisable at $1.00 per share, below the current stock price of $1.18, indicating likely and significant dilution for existing shareholders. This financing, representing a substantial portion of the company's market capitalization, highlights ongoing capital needs and could exert downward pressure on the stock as warrants are exercised.